Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 26, 1996 - Issue 10
17
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Disposition in rat of [2-3H]-trans-4-hydroxy-2,3-nonenal, a product of lipid peroxidation

, , , &
Pages 1087-1100 | Received 17 Apr 1996, Published online: 27 Aug 2009
 

Abstract

1. 4-Hydroxy-2,3-nonenal (HNE) is an end product of lipid peroxidation (LPO) and a well known cytotoxic aldehyde that exhibits a variety of biological effects. In this study the in vivo disposition and covalent binding of i.p. administered [2-3H]HNE was examined in the rat.

2. It was found that several metabolites of [2-3H]HNE are excreted in urine among which at least four mercapturic acids. 1,4-Dihydroxynonane mercapturic acid (DHN-MA) appeared to be the most abundant mercapturic acid excreted in urine (3·5% of the dose) and the excretion of the other three mercapturic acids amounted to 2% of the dose.

3. Within 48 h following i.p. administration of 5 or 25 μmol/kg bodyweight [2-3H]HNE (specific activity 4 μCi/μmol) about 25% of the radioactivity was excreted in urine, whereas 18% of the radioactivity appeared in the faeces.

4. After 48 h, 7% of the radioactivity was still present in the liver and 0·2% in other organs, but this radioactivity appeared not to be covalently bound to cellular macro-molecules. It was found that only 0·13% of the radioactivity was covalently bound in the liver and even less in the other organs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.